Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Advances in Clinical Chemistry|June 28, 2016
Transferrin Saturation: A Body Iron BiomarkerM E Elsayed, M U Sharif, A G StackAdvances in Renal Replacement Therapy|February 15, 2000
Renal replacement therapy in the elderly: medical, ethical, and psychosocial considerationsA G Stack, J M MessanaAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 31, 2001
A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patientsA G Stack, W E BloembergenClinical Therapeutics|April 22, 1999
S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomideJ B Zeldis, B A Williams, S D Thomas, et al.QJM : Monthly Journal of the Association of Physicians|March 7, 2014
Transferrin saturation ratio and risk of total and cardiovascular mortality in the general populationA G Stack, A I Mutwali, H T Nguyen, et al.Journal of Contaminant Hydrology|May 20, 2008
Distribution and variability of redox zones controlling spatial variability of arsenic in the Mississippi River Valley alluvial aquifer, southeastern ArkansasM U Sharif, R K Davis, K F Steele, et al.QJM : Monthly Journal of the Association of Physicians|March 18, 2014
Plasma fibrinogen associates independently with total and cardiovascular mortality among subjects with normal and reduced kidney function in the general populationA G Stack, U Donigiewicz, A A Abdalla, et al.Saudi Journal of Medicine & Medical Sciences|February 12, 2026
Fungal Peritonitis in Peritoneal Dialysis: An 18-year Experience from Nizwa Hospital, Sultanate of OmanJehad Al Laham, Khalfan Alshaaili, Hanaa M E Elsayed, et al.QJM : Monthly Journal of the Association of Physicians|April 9, 2013
Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortalityA G Stack, A Hanley, L F Casserly, et al.The Gulf Journal of Oncology|February 19, 2010
A matched case-control study of Triple negative vs. HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high risk features and poor outcomeJ M Zekri, E Ibrahim, A M Al-Gahmi, et al.Pageof 2